Tracleer, which improves pulmonary arterial hypertension patients’ exercise capability, may decrease the effectives of two other PAH treatments, Revatio and Adcirca,…
Janet Stewart, MSc
Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Janet Stewart, MSc
A Japanese study of nine families members who have heritable pulmonary arterial hypertension (HPAH) found different mutations in the same…
A majority of patients with pulmonary arterial hypertension (PAH) have abnormalities in the lower left chamber of the heart, or…
Eliminating a long noncoding RNA reduced heart-muscle enlargement in mice with pulmonary hypertension (PH), according to a study. The RNA,…
High levels of a protein called galectin-3 are associated with pulmonary hypertension deaths, according to a study that says targeting…
In a moderately sized group of patients with pulmonary hypertension (PH), nonsustained ventricular tachycardia (nsVT) occurred more often than previously reported,…
A recent study showed that patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) responded well to a combination therapy with…